Drug-Related Hypertension Associated with the Efficacy of Apatinib on Hepatocellular Carcinoma [Corrigendum]
Yang X, Hou Z, Zhu K, et al. Cancer Manag Res. 2020;12:3163– 3173. The authors have advised there is an error with Figure 2 on page 3170. The figure parts C-H do not match the description in the figure caption or figure citations throughout the text. Th...
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-06-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/corrigendum-drug-related-hypertension-associated-with-the-efficacy-of--peer-reviewed-article-CMAR |
id |
doaj-a4fdd7d837e0455388b04dd2b541193f |
---|---|
record_format |
Article |
spelling |
doaj-a4fdd7d837e0455388b04dd2b541193f2020-11-25T03:11:27ZengDove Medical PressCancer Management and Research1179-13222020-06-01Volume 124169417054274Drug-Related Hypertension Associated with the Efficacy of Apatinib on Hepatocellular Carcinoma [Corrigendum]Yang XHou ZZhu KZhang SGu XWang ZMu HZhou HChen PZhu XCui YLi QLi HZhang TYang X, Hou Z, Zhu K, et al. Cancer Manag Res. 2020;12:3163– 3173. The authors have advised there is an error with Figure 2 on page 3170. The figure parts C-H do not match the description in the figure caption or figure citations throughout the text. The authors apologize for this error. Read the original articlehttps://www.dovepress.com/corrigendum-drug-related-hypertension-associated-with-the-efficacy-of--peer-reviewed-article-CMARvegfr-2htnhccresistanceliver cancer. |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Yang X Hou Z Zhu K Zhang S Gu X Wang Z Mu H Zhou H Chen P Zhu X Cui Y Li Q Li H Zhang T |
spellingShingle |
Yang X Hou Z Zhu K Zhang S Gu X Wang Z Mu H Zhou H Chen P Zhu X Cui Y Li Q Li H Zhang T Drug-Related Hypertension Associated with the Efficacy of Apatinib on Hepatocellular Carcinoma [Corrigendum] Cancer Management and Research vegfr-2 htn hcc resistance liver cancer. |
author_facet |
Yang X Hou Z Zhu K Zhang S Gu X Wang Z Mu H Zhou H Chen P Zhu X Cui Y Li Q Li H Zhang T |
author_sort |
Yang X |
title |
Drug-Related Hypertension Associated with the Efficacy of Apatinib on Hepatocellular Carcinoma [Corrigendum] |
title_short |
Drug-Related Hypertension Associated with the Efficacy of Apatinib on Hepatocellular Carcinoma [Corrigendum] |
title_full |
Drug-Related Hypertension Associated with the Efficacy of Apatinib on Hepatocellular Carcinoma [Corrigendum] |
title_fullStr |
Drug-Related Hypertension Associated with the Efficacy of Apatinib on Hepatocellular Carcinoma [Corrigendum] |
title_full_unstemmed |
Drug-Related Hypertension Associated with the Efficacy of Apatinib on Hepatocellular Carcinoma [Corrigendum] |
title_sort |
drug-related hypertension associated with the efficacy of apatinib on hepatocellular carcinoma [corrigendum] |
publisher |
Dove Medical Press |
series |
Cancer Management and Research |
issn |
1179-1322 |
publishDate |
2020-06-01 |
description |
Yang X, Hou Z, Zhu K, et al. Cancer Manag Res. 2020;12:3163– 3173.
The authors have advised there is an error with Figure 2 on page 3170. The figure parts C-H do not match the description in the figure caption or figure citations throughout the text.
The authors apologize for this error.
Read the original article |
topic |
vegfr-2 htn hcc resistance liver cancer. |
url |
https://www.dovepress.com/corrigendum-drug-related-hypertension-associated-with-the-efficacy-of--peer-reviewed-article-CMAR |
work_keys_str_mv |
AT yangx drugrelatedhypertensionassociatedwiththeefficacyofapatinibonhepatocellularcarcinomacorrigendum AT houz drugrelatedhypertensionassociatedwiththeefficacyofapatinibonhepatocellularcarcinomacorrigendum AT zhuk drugrelatedhypertensionassociatedwiththeefficacyofapatinibonhepatocellularcarcinomacorrigendum AT zhangs drugrelatedhypertensionassociatedwiththeefficacyofapatinibonhepatocellularcarcinomacorrigendum AT gux drugrelatedhypertensionassociatedwiththeefficacyofapatinibonhepatocellularcarcinomacorrigendum AT wangz drugrelatedhypertensionassociatedwiththeefficacyofapatinibonhepatocellularcarcinomacorrigendum AT muh drugrelatedhypertensionassociatedwiththeefficacyofapatinibonhepatocellularcarcinomacorrigendum AT zhouh drugrelatedhypertensionassociatedwiththeefficacyofapatinibonhepatocellularcarcinomacorrigendum AT chenp drugrelatedhypertensionassociatedwiththeefficacyofapatinibonhepatocellularcarcinomacorrigendum AT zhux drugrelatedhypertensionassociatedwiththeefficacyofapatinibonhepatocellularcarcinomacorrigendum AT cuiy drugrelatedhypertensionassociatedwiththeefficacyofapatinibonhepatocellularcarcinomacorrigendum AT liq drugrelatedhypertensionassociatedwiththeefficacyofapatinibonhepatocellularcarcinomacorrigendum AT lih drugrelatedhypertensionassociatedwiththeefficacyofapatinibonhepatocellularcarcinomacorrigendum AT zhangt drugrelatedhypertensionassociatedwiththeefficacyofapatinibonhepatocellularcarcinomacorrigendum |
_version_ |
1724654118893518848 |